儿童MOG抗体相关疾病的不典型临床表型
Atypical Clinical Phenotype of MOG Antibody-Related Disease in Children
DOI: 10.12677/ACM.2023.133694, PDF,   
作者: 王晓宇, 李秀娟*:重庆医科大学附属儿童医院神经内科,儿童发育疾病研究教育部重点实验室,国家儿童健康与疾病临床医学研究中心,儿科学重庆市重点实验室,重庆
关键词: 髓鞘少突胶质细胞糖蛋白抗体相关疾病(MOGAD)不典型临床表型儿童Myelin Oligodendrocyte Glycoprotein-IgG Associated Disorders Atypical Clinical Phenotype Chil-dren
摘要: 髓鞘少突胶质细胞糖蛋白免疫球蛋G抗体(MOG-IgG)相关疾病(MOGAD)典型临床表型,如急性播散性脑脊髓炎(ADEM)、视神经炎(ON)、视神经脊髓炎谱系疾病(NMOSD)、横贯性脊髓炎(TM)已被临床医生所熟知,但近年来逐渐报道了一些少见的临床表型,如皮质脑炎、孤立性癫痫发作、脑白质营养不良样表型、无菌性脑膜炎、髓鞘少突胶质细胞糖蛋白抗体相关疾病与抗N-甲基-D-天冬氨酸受体脑炎重叠综合征等,而由于这些少见临床表型在临床和影像上表现不典型,临床医生对其仍缺乏系统的认识,常常容易误诊误治或延迟诊治。为进一步提高临床医生对儿童MOGAD不典型临床表型的认识,本文对上述MOGAD的少见临床表型进行了归纳总结。
Abstract: The typical clinical phenotypes of myelin oligodendrocytes glycoprotein immunoglobulin egg G an-tibody (MOG-IgG) related diseases (MOGAD), such as acute disseminated encephalomyelitis (ADEM), optic neuritis (ON), neuromyelitis optica spectrum disease (NMOSD), transverse myelitis (TM), have been well known by clinicians, but in recent years, some rare clinical phenotypes, such as cerebral cortical encephalitis, isolated seizures, leukodystrophy-like phenotypes, aseptic meningitis, the overlapping syndrome of myelin oligodendrocyte glycoprotein antibody-associated disorders and anti-N-methyl-D-aspartate receptor encephalitis (MNOS), etc., have been gradually reported. Due to the atypical clinical and imaging manifestations of these rare clinical phenotypes, clinicians still lack systematic understanding of them, and are often prone to misdiagnosis, misdiagnosis or de-layed diagnosis and treatment. In order to further improve clinicians’ understanding of the atypical clinical phenotypes of MOGAD in children, this article summarizes and analyzes the rare clinical phenotypes of MOGAD mentioned above.
文章引用:王晓宇, 李秀娟. 儿童MOG抗体相关疾病的不典型临床表型[J]. 临床医学进展, 2023, 13(3): 4860-4866. https://doi.org/10.12677/ACM.2023.133694

参考文献

[1] Jarius, S., Paul, F., Aktas, O., Asgari, N., Dale, R.C., de Seze, J., Franciotta, D., Fujihara, K., Jacob, A., Kim, H.J., Klei-ter, I., Kümpfel, T., Levy, M., Palace, J., Ruprecht, K., Saiz, A., Trebst, C., Weinshenker, B.G. and Wildemann, B. (2018) MOG Encephalomyelitis: International Recommendations on Diagnosis and Antibody Testing. Journal of Neuroinflam-mation, 15, Article No. 134. [Google Scholar] [CrossRef] [PubMed]
[2] Bruijstens, A.L., Lechner, C., Flet-Berliac, L., Deiva, K., Neuteboom, R.F., Hemingway, C., Wassmer, E., E.U. Paediatric MOG Consortium, Bau-mann, M., Bartels, F., Finke, C., Adamsbaum, C., Hacohen, Y. and Rostasy, K. (2020) E.U. Paediatric MOG Consorti-um Consensus: Part 1—Classification of Clinical Phenotypes of Paediatric Myelin Oligodendrocyte Glycoprotein Anti-body-Associated Disorders. European Journal of Paediatric Neurology: EJPN: Official Journal of the European Paedi-atric Neurology Society, 29, 2-13. [Google Scholar] [CrossRef] [PubMed]
[3] Ogawa, R., Nakashima, I., Takahashi, T., Kaneko, K., Akaishi, T., Takai, Y., Sato, D.K., Nishiyama, S., Misu, T., Kuroda, H., Aoki, M. and Fuji-hara, K. (2017) MOG Antibody-Positive, Benign, Unilateral, Cerebral Cortical Encephalitis with Epilepsy. Neurology(R) Neuroimmunology & Neuroinflammation, 4, e322. [Google Scholar] [CrossRef
[4] Budhram, A., Mirian, A., Le, C., Hosseini-Moghaddam, S.M., Sharma, M. and Nicolle, M.W. (2019) Unilateral Cortical FLAIR-Hyperintense Lesions in Anti-MOG-Associated Encephalitis with Seizures (FLAMES): Characterization of a Distinct Clinico-Radiographic Syndrome. Journal of Neu-rology, 266, 2481-2487. [Google Scholar] [CrossRef] [PubMed]
[5] Shu, H., Ding, M., Shang, P., Song, J., Lang, Y. and Cui, L. (2022) Myelin Oligodendrocyte Glycoprotein Antibody Associated Cerebral Cortical Encephalitis: Case Reports and Re-view of Literature. Frontiers in Human Neuroscience, 15, Article ID: 782490. [Google Scholar] [CrossRef] [PubMed]
[6] Wang, Y.F., Liu, X.W., Lin, J.M., Liang, J.Y., Zhao, X.H. and Wang, S.J. (2021) The Clinical Features of FLAIR- Hyperintense Lesions in Anti-MOG Antibody Associated Cerebral Cortical Encephalitis with Seizures: Case Reports and Literature Review. Frontiers in Immunology, 12, Article ID: 582768. [Google Scholar] [CrossRef] [PubMed]
[7] Tokumoto, K., Nishida, T., Kawaguchi, N., Kaneko, K., Takahashi, T. and Takahashi, Y. (2022) Electroclinical Features of Seizures in Myelin Oligodendrocyte Glycoprotein An-tibody-Associated Cerebral Cortical Encephalitis: A Case Report and Literature Review. Seizure, 98, 13-18. [Google Scholar] [CrossRef] [PubMed]
[8] Jain, K., Cherian, A., et al. (2021) FLAMES: A Novel Burning Entity in MOG IgG Associated Disease. Multiple Sclerosis and Related Disorders, 49, Article ID: 102759. [Google Scholar] [CrossRef] [PubMed]
[9] 周季, 丁昌红, 张炜华, 卓秀伟, 李久伟, 巩帅, 关鸿志, 方方, 朱筱筠, 程华, 任晓暾, 等. 以皮质脑炎为表型的儿童抗髓鞘少突胶质细胞糖蛋白抗体相关疾病的临床特点[J]. 中华医学杂志, 2020, 100(25): 1952-1955.
[10] Armangue, T., Olivé-Cirera, G., Martínez-Hernandez, E., Sepul-veda, M., Ruiz-Garcia, R., Muñoz-Batista, M., Ariño, H., González-Álvarez, V., Felipe-Rucián, A., Jesús Mar-tínez-González, M., Cantarín-Extremera, V., Concepción Miranda-Herrero, M., Monge-Galindo, L., Tomás-Vila, M., Miravet, E., Málaga, I., Arrambide, G., Auger, C., Tintoré, M., Montalban, X. and Spanish Pediatric Anti-MOG Study Group (2020) Associations of Paediatric Demyelinating and Encephalitic Syndromes with Myelin Oligodendrocyte Gly-coprotein Antibodies: A Multicentre Observational Study. The Lancet. Neurology, 19, 234-246. [Google Scholar] [CrossRef
[11] Ramanathan, S., O’grady, G.L., Malone, S., Spooner, C.G., Brown, D.A., Gill, D., Brilot, F. and Dale, R.C. (2019) Isolated Seizures during the First Episode of Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Demyelination in Children. Developmental Medicine and Child Neurology, 61, 610-614. [Google Scholar] [CrossRef] [PubMed]
[12] Foiadelli, T., Gastaldi, M., Scaranzin, S., Franciotta, D. and Savasta, S. (2020) Seizures and Myelin Oligodendrocyte Glycoprotein (MOG) Antibodies: Two Paradigmatic Cases and a Review of the Literature. Multiple Sclerosis and Related Disorders, 41, Article ID: 102011. [Google Scholar] [CrossRef] [PubMed]
[13] Liu, K., Sun, S., Cui, J., Zhang, L., Zhang, K. and Zhang, L. (2021) Seizures in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders and Related Immune Factors. Seizure, 92, 216-220. [Google Scholar] [CrossRef] [PubMed]
[14] Hacohen, Y., Rossor, T., Mankad, K., Chong, W., Lux, A., Wassmer, E., Lim, M., Barkhof, F., Ciccarelli, O. and Hemingway, C. (2018) “Leukodystrophy-Like” Phenotype in Children with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Developmental Medicine and Child Neurology, 60, 417-423. [Google Scholar] [CrossRef] [PubMed]
[15] Ortiz de Zarate, Z., Felipe-Rucián, A., Sánchez-Montáñez, Á., Armangué, T. and Gómez-Andrés, D. (2022) “Leukodystrophy-Like” Phenotype in Anti-MOG Antibody-Associated Disorders. Neuropediatrics, 53, 147-148. [Google Scholar] [CrossRef] [PubMed]
[16] Baumann, M., Bartels, F., Finke, C., Adamsbaum, C., Hacohen, Y., Rostásy, K. and E.U. Paediatric MOG Consortium (2020) E.U. Paediatric MOG Consortium Consensus: Part 2—Neuroimaging Features of Paediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders. Euro-pean Journal of Paediatric Neurology: EJPN: Official Journal of the European Paediatric Neurology Society, 29, 14-21. [Google Scholar] [CrossRef] [PubMed]
[17] Shi, B., Jiang, W., He, M., Sun, H., Sun, X., Yang, Y., Yao, J., Wu, L. and Huang, D. (2020) Aseptic Meningitis as an Atypical Manifestation of Neuromyelitis Optica Spectrum Disor-der Flare. Multiple Sclerosis and Related Disorders, 41, Article ID: 102013. [Google Scholar] [CrossRef] [PubMed]
[18] Leinert, J., Neumaier-Probst, E., Kutschke, G. and Tenenbaum, T. (2020) MOG Antibody Associated Demyelinating Syndrome Presenting as Aseptic Meningitis in a 6-Year-Old Boy. Multiple Sclerosis and Related Disorders, 41, Article ID: 102050. [Google Scholar] [CrossRef] [PubMed]
[19] Udani, V., Badheka, R. and Desai, N. (2021) Prolonged Fever: An Atypical Presentation in MOG Antibody-Associated Disorders. Pediatric Neurology, 122, 1-6. [Google Scholar] [CrossRef] [PubMed]
[20] Zhong, X., Chang, Y., Tan, S., Wang, J., Sun, X., Wu, A., Peng, L., Lau, A.Y., Kermode, A.G. and Qiu, W. (2019) Relapsing Optic Neuritis and Meningoencephalitis in a Child: Case Report of Delayed Diagnosis of MOG-IgG Syndrome. BMC Neurology, 19, 94. [Google Scholar] [CrossRef] [PubMed]
[21] Song, X., Ma, J., Li, X. and Jiang, L. (2022) Children Suspected of Having Intracranial Infection with Normal Brain Magnetic Resonance Imaging May Be Associated with the Myelin Oligodendrocyte Glycoprotein Antibody. Brain & Development, 44, 281-286. [Google Scholar] [CrossRef] [PubMed]
[22] Titulaer, M.J., Höftberger, R., Iizuka, T., Leypoldt, F., McCracken, L., Cellucci, T., Benson, L.A., Shu, H., Irioka, T., Hirano, M., Singh, G., Cobo Calvo, A., Kaida, K., Mo-rales, P.S., Wirtz, P.W., Yamamoto, T., Reindl, M., Rosenfeld, M.R., Graus, F., Saiz, A. and Dalmau, J. (2014) Over-lapping Demyelinating Syndromes and Anti-N-methyl-D-aspartate Receptor Encephalitis. Annals of Neurology, 75, 411-428. [Google Scholar] [CrossRef] [PubMed]
[23] Fan, S., Xu, Y., Ren, H., Guan, H., Feng, F., Gao, X., Ding, D., Fang, F., Shan, G., Guan, T., Zhang, Y., Dai, Y., Yao, M., Peng, B., Zhu, Y. and Cui, L. (2018) Comparison of Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Disease and AQP4-IgG-Positive Neuromyelitis Optica Spectrum Dis-order (NMOSD) When They Co-Exist with Anti-NMDA (N-methyl-D-aspartate) Receptor Encephalitis. Multiple Scle-rosis and Related Disorders, 20, 144-152. [Google Scholar] [CrossRef] [PubMed]
[24] Nan, D., Zhang, Y., Han, J. and Jin, T. (2021) Clinical Features and Management of Coexisting Anti-N-methyl-D- aspartate Receptor Encephalitis and Myelin Oligodendrocyte Glyco-protein Antibody-Associated Encephalomyelitis: A Case Report and Review of the Literature. Neurological Sciences: Of-ficial Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 42, 847-855. [Google Scholar] [CrossRef] [PubMed]
[25] Zhao, C., Liu, P., Zhao, D., Ding, J., Zhang, G., Li, H. and Guo, J. (2022) Coexistence of Myelin Oligodendrocyte Glycoprotein Immunoglobulin G and Neuronal or Glial Antibodies in the Central Nervous System: A Systematic Review. Brain Sciences, 12, 995. [Google Scholar] [CrossRef] [PubMed]
[26] Hou, C., Wu, W., Tian, Y., Zhang, Y., Zhu, H., Zeng, Y., Peng, B., Zheng, K., Li, X. and Chen, W. (2020) Clinical Analysis of Anti-NMDAR Encephalitis Combined with MOG Antibody in Children. Multiple Sclerosis and Related Disorders, 42, Article ID: 102018. [Google Scholar] [CrossRef] [PubMed]
[27] 沈敏慧, 俞海, 刘小妮, 杨文波, 张祥, 李亚蓉, 张晓玲, 陈向军, 等. 抗髓鞘少突胶质细胞糖蛋白抗体合并抗N-甲基-D-天冬氨酸受体抗体阳性患者临床特点分析[J]. 中华神经科杂志, 2021, 54(9): 898-907.
[28] 巩帅, 张炜华, 任海涛, 李久伟, 周季, 程华, 卓秀伟, 任长红, 韩彤立, 吕俊兰, 丁昌红, 方方, 关鸿志, 任晓暾等. 儿童MOG抗体病与抗NMDAR脑炎重叠综合征临床观察[J]. 中华儿科杂志, 2020, 58(7): 581-585.
[29] Ding, J., Li, X. and Tian, Z. (2021) Clinical Features of Coexisting An-ti-NMDAR and MOG Antibody-Associated Encephalitis: A Systematic Review and Meta-Analysis. Frontiers in Neu-rology, 12, Article ID: 711376. [Google Scholar] [CrossRef] [PubMed]
[30] Mao, L., Yang, L., Kessi, M., He, F., Zhang, C., Wu, L., Yin, F. and Peng, J. (2019) Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Diseases in Children in Central South Chi-na: Clinical Features, Treatments, Influencing Factors, and Outcomes. Frontiers in Neurology, 10, 868. [Google Scholar] [CrossRef] [PubMed]
[31] Bruijstens, A.L., Wendel, E.M., Lechner, C., Bartels, F., Finke, C., Breu, M., Flet-Berliac, L., de Chalus, A., Adamsbaum, C., Capobianco, M., Laetitia, G., Hacohen, Y., Hemingway, C., Wassmer, E., Lim, M., Baumann, M., Wickström, R., Armangue, T., Rostasy, K., Deiva, K. and Neuteboom, R.F. (2020) E.U. Paediatric MOG Consortium Consensus: Part 5—Treatment of Paediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders. European Journal of Paediatric Neurology: EJPN: Official Journal of the European Paediatric Neurology Society, 29, 41-53. [Google Scholar] [CrossRef] [PubMed]
[32] Whittam, D.H., Co-bo-Calvo, A., Lopez-Chiriboga, A.S., Pardo, S., Gornall, M., Cicconi, S., Brandt, A., Berek, K., Berger, T., Jelcic, I., Gombolay, G., Oliveira, L.M., Callegaro, D., Kaneko, K., Misu, T., Capobianco, M., Gibbons, E., Karthikeayan, V., Brochet, B., Audoin, B. and Jacob, A. (2020) Treatment of MOG-IgG-Associated Disorder with Rituximab: An Interna-tional Study of 121 Patients. Multiple Sclerosis and Related Disorders, 44, Article ID: 102251. [Google Scholar] [CrossRef] [PubMed]